Federica Grosso

Statistics

Publications

101

Citations

7.7K

H-Index

Active since

1977

Affiliations

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

University of Turin

Mario Negri Institute for Pharmacological Research

Federica Grosso is an author at Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

1977–2024

101

Publications

101

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020 · 624 citations · Full text

Medicine, Oncology, Clinical Epidemiology +3

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

Federica Grosso, Robin L. Jones, George D. Demetri et al. · The Lancet Oncology · 2007 · 449 citations

Medicine, Oncology, Surgery +13

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial

Michele Maio, Arnaud Scherpereel, Luana Calabrò et al. · The Lancet Oncology · 2017 · 424 citations

Medicine, Oncology, Pharmacotherapy +11

Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade

Patrizio Caturegli, Giulia Di Dalmazi, Martina Lombardi et al. · American Journal Of Pathology · 2016 · 379 citations · Full text

Life Sciences, Endocrinology, Immunology +11

Imatinib mesylate in chordoma

Paolo G. Casali, A. Messina, Silvia Stacchiotti et al. · Cancer · 2004 · 269 citations · Full text

Medicine, Oncology, Pharmacology +11

1–5 of 101